Ray Dalio Trans Medics Group, Inc. Transaction History
Bridgewater Associates, LP
- $21.1 Billion
- Q4 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 3,463 shares of TMDX stock, worth $305,575. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,463
Previous 4,872
28.92%
Holding current value
$305,575
Previous $764,000
71.86%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding TMDX
# of Institutions
344Shares Held
30MCall Options Held
671KPut Options Held
858K-
Vanguard Group Inc Valley Forge, PA3.64MShares$321 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$233 Million0.01% of portfolio
-
State Street Corp Boston, MA1.36MShares$120 Million0.0% of portfolio
-
Fil LTD Hamilton, D01MShares$88.3 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3993KShares$87.6 Million0.07% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.81B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...